Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03110380
Brief Title: Switching to a Fixed Dose Combination of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) in Human Immunodeficiency Virus Type 1 (HIV-1) Infected Adults Who Are Virologically Suppressed

First Submitted : April 7, 2017
First Submitted that Met QC Criteria : April 7, 2017
First Posted : April 12, 2017

Results First Submitted : November 1, 2019
Results First Submitted that Met QC Criteria : November 1, 2019
Results First Posted : November 20, 2019

Last Update Submitted that Met QC Criteria : December 14, 2021
Last Update Posted : January 11, 2022